Sunday, April 24, 2016

Clinical research study of an investigational drug for oral ulcers associated with Behcet's Disease



Behcet's disease, also known as Behcet's syndrome, is a rare disorder that causes inflammation in blood vessels throughout the body. Signs and symptoms may include mouth sores, eye inflammation, skin rashes and lesions, and genital sores that vary from person to person and may come and go on their own. The exact cause of Behcet's disease is unknown.

This Celgene study will test whether the investigational drug apremilast is better than placebo (inactive substance in the same form as the drug) for oral ulcers in subjects with active Behcet's disease. Other manifestations of the disease will also be evaluated. This study also will test how well the body tolerates apremilast.

Last day to join the study is December 31, 2016.

Learn more here: